Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FCX9J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,201
Award facts
- Contract value 100% obligated
- $21,201.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $21,201.45 by the Defense Logistics Agency for the supply of RINVOQ ER 15 mg tablets (30-unit packages). This is a firm fixed-price, non-set-aside contract with a completion deadline of January 7, 2026, awarded on January 6, 2026. The pharmaceutical product will be delivered from the company's Conshohocken, Pennsylvania location. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The company maintains significant contract relationships with the Defense Logistics Agency and consistently delivers a diverse portfolio of pharmaceutical products across multiple therapeutic domains through competitively awarded delivery orders. The DLA Troop Support is planning to establish the Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among the qualified vendors to serve Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FCX9J?
SPE2DR26FCX9J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FCX9J worth?
The government has obligated $21,201 on SPE2DR26FCX9J.
Is contract SPE2DR26FCX9J an order under another contract?
Yes. SPE2DR26FCX9J is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCX9J competed?
The extent of competition for SPE2DR26FCX9J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award